Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1984 1
1993 1
1996 3
1997 6
1998 6
1999 7
2000 8
2001 7
2002 9
2003 19
2004 24
2005 21
2006 17
2007 23
2008 15
2009 25
2010 32
2011 36
2012 58
2013 58
2014 50
2015 41
2016 41
2017 52
2018 59
2019 36
2020 63
2021 55
2022 63
2023 43
2024 36

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

801 results

Results by year

Filters applied: . Clear all
Page 1
Multiple sclerosis - a review.
Dobson R, Giovannoni G. Dobson R, et al. Among authors: giovannoni g. Eur J Neurol. 2019 Jan;26(1):27-40. doi: 10.1111/ene.13819. Epub 2018 Nov 18. Eur J Neurol. 2019. PMID: 30300457 Review.
Long COVID or post COVID-19 syndrome.
Lechner-Scott J, Levy M, Hawkes C, Yeh A, Giovannoni G. Lechner-Scott J, et al. Among authors: giovannoni g. Mult Scler Relat Disord. 2021 Oct;55:103268. doi: 10.1016/j.msard.2021.103268. Epub 2021 Sep 17. Mult Scler Relat Disord. 2021. PMID: 34601388 Free PMC article. No abstract available.
Smouldering multiple sclerosis: the 'real MS'.
Giovannoni G, Popescu V, Wuerfel J, Hellwig K, Iacobaeus E, Jensen MB, García-Domínguez JM, Sousa L, De Rossi N, Hupperts R, Fenu G, Bodini B, Kuusisto HM, Stankoff B, Lycke J, Airas L, Granziera C, Scalfari A. Giovannoni G, et al. Ther Adv Neurol Disord. 2022 Jan 25;15:17562864211066751. doi: 10.1177/17562864211066751. eCollection 2022. Ther Adv Neurol Disord. 2022. PMID: 35096143 Free PMC article. Review.
Vitamin D supplementation.
Dobson R, Cock HR, Brex P, Giovannoni G. Dobson R, et al. Among authors: giovannoni g. Pract Neurol. 2018 Feb;18(1):35-42. doi: 10.1136/practneurol-2017-001720. Epub 2017 Sep 25. Pract Neurol. 2018. PMID: 28947637 Review.
Stiff person syndrome.
Hadavi S, Noyce AJ, Leslie RD, Giovannoni G. Hadavi S, et al. Among authors: giovannoni g. Pract Neurol. 2011 Oct;11(5):272-82. doi: 10.1136/practneurol-2011-000071. Pract Neurol. 2011. PMID: 21921002 Review.
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Hauser SL, Bar-Or A, Comi G, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Montalban X, Rammohan KW, Selmaj K, Traboulsee A, Wolinsky JS, Arnold DL, Klingelschmitt G, Masterman D, Fontoura P, Belachew S, Chin P, Mairon N, Garren H, Kappos L; OPERA I and OPERA II Clinical Investigators. Hauser SL, et al. Among authors: giovannoni g. N Engl J Med. 2017 Jan 19;376(3):221-234. doi: 10.1056/NEJMoa1601277. Epub 2016 Dec 21. N Engl J Med. 2017. PMID: 28002679 Free article. Clinical Trial.
The Multiple Sclerosis Care Unit.
Soelberg Sorensen P, Giovannoni G, Montalban X, Thalheim C, Zaratin P, Comi G. Soelberg Sorensen P, et al. Among authors: giovannoni g. Mult Scler. 2019 Apr;25(5):627-636. doi: 10.1177/1352458518807082. Epub 2018 Oct 23. Mult Scler. 2019. PMID: 30351211 Free PMC article. Review.
Social determinants of health in multiple sclerosis.
Dobson R, Rice DR, D'hooghe M, Horne R, Learmonth Y, Mateen FJ, Marck CH, Reyes S, Williams MJ, Giovannoni G, Ford HL. Dobson R, et al. Among authors: giovannoni g. Nat Rev Neurol. 2022 Dec;18(12):723-734. doi: 10.1038/s41582-022-00735-5. Epub 2022 Nov 11. Nat Rev Neurol. 2022. PMID: 36369488 Free PMC article. Review.
Inhibition of CD40L with Frexalimab in Multiple Sclerosis.
Vermersch P, Granziera C, Mao-Draayer Y, Cutter G, Kalbus O, Staikov I, Dufek M, Saubadu S, Bejuit R, Truffinet P, Djukic B, Wallstroem E, Giovannoni G; Frexalimab Phase 2 Trial Group. Vermersch P, et al. Among authors: giovannoni g. N Engl J Med. 2024 Feb 15;390(7):589-600. doi: 10.1056/NEJMoa2309439. N Engl J Med. 2024. PMID: 38354138 Clinical Trial.
801 results